Activist 13D/13G Filings - Clarus Lifesciences III L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-01-12
4:31 pm
Sale
13DImago BioSciences Inc.
IMGO
Clarus Lifesciences III L.P.0
0.000%
-2,436,732decrease
(Position Closed)
View
2022-04-01
5:18 pm
Sale
13DImago BioSciences Inc.
IMGO
Clarus Lifesciences III L.P.2,436,732
7.200%
-938,305decrease
(-27.80%)
View
2022-01-12
4:30 pm
Sale
13DESSA Pharma Inc.
EPIX
Clarus Lifesciences III L.P.2,187,912
4.960%
-1,291,202decrease
(-37.11%)
View
2021-07-30
4:32 pm
Purchase
13DImago BioSciences Inc.
IMGO
Clarus Lifesciences III L.P.3,375,037
10.500%
3,375,037increase
(New Position)
View
2020-07-09
4:48 pm
Sale
13DEntasis Therapeutics Holdings Inc.
ETTX
Clarus Lifesciences III L.P.1,339,836
4.900%
-283,569decrease
(-17.47%)
View
2020-05-01
5:01 pm
Unchanged
13DEntasis Therapeutics Holdings Inc.
ETTX
Clarus Lifesciences III L.P.1,623,405
11.100%
0
(Unchanged)
View